Free Trial
OTCMKTS:CMPD

CompuMed (CMPD) Stock Price, News & Analysis

CompuMed logo
$3.06 0.00 (0.00%)
As of 05/7/2025

About CompuMed Stock (OTCMKTS:CMPD)

Key Stats

Today's Range
$3.06
$3.06
50-Day Range
$2.90
$3.80
52-Week Range
$1.61
$4.70
Volume
N/A
Average Volume
2,038 shs
Market Capitalization
$4.06 million
P/E Ratio
18.01
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

CompuMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

CMPD MarketRank™: 

CompuMed scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CompuMed.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CompuMed is 18.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.18.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CompuMed is 18.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 24.94.

  • Price to Book Value per Share Ratio

    CompuMed has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CompuMed's valuation and earnings.
  • Percentage of Shares Shorted

    0.48% of the float of CompuMed has been sold short.
  • Short Interest Ratio / Days to Cover

    CompuMed has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CompuMed has recently decreased by 1.96%, indicating that investor sentiment is improving.
  • Dividend Yield

    CompuMed does not currently pay a dividend.

  • Dividend Growth

    CompuMed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.48% of the float of CompuMed has been sold short.
  • Short Interest Ratio / Days to Cover

    CompuMed has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CompuMed has recently decreased by 1.96%, indicating that investor sentiment is improving.
  • News Sentiment

    CompuMed has a news sentiment score of -0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for CompuMed this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, CompuMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.00% of the stock of CompuMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about CompuMed's insider trading history.
Receive CMPD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CompuMed and its competitors with MarketBeat's FREE daily newsletter.

CMPD Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
CMPD to discuss theft ring case
Compumed Inc.
See More Headlines

CMPD Stock Analysis - Frequently Asked Questions

CompuMed's stock was trading at $3.81 on January 1st, 2025. Since then, CMPD stock has decreased by 19.6% and is now trading at $3.0625.
View the best growth stocks for 2025 here
.

CompuMed, Inc. (OTCMKTS:CMPD) announced its quarterly earnings results on Monday, December, 16th. The company reported $0.02 earnings per share (EPS) for the quarter. CompuMed had a net margin of 3.44% and a trailing twelve-month return on equity of 6.96%.

CompuMed's stock reverse split before market open on Saturday, May 21st 2022. The 1-25 reverse split was announced on Saturday, May 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Saturday, May 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of CMPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CompuMed investors own include Yamana Gold (AUY) and Agnico Eagle Mines (AEM).

Company Calendar

Last Earnings
12/16/2024
Today
5/08/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Data processing & preparation
Sub-Industry
Business Services
Current Symbol
OTCMKTS:CMPD
CIK
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
18.01
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$190,000.00
Pretax Margin
2.29%

Debt

Sales & Book Value

Annual Sales
$6.22 million
Cash Flow
$0.42 per share
Price / Cash Flow
7.24
Book Value
$2.42 per share
Price / Book
1.27

Miscellaneous

Free Float
1,034,000
Market Cap
$4.06 million
Optionable
Not Optionable
Beta
-0.02
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:CMPD) was last updated on 5/9/2025 by MarketBeat.com Staff
From Our Partners